Last updated: August 4, 2025
Introduction
South Korea’s patent KR101078636 pertains to innovative pharmaceutical technology. As a leading jurisdiction for drug patents, South Korea’s patent landscape combines robust legal protection and a competitive environment for pharmaceuticals. This analysis provides an in-depth review of the patent’s scope, claims, and its position within the broader patent landscape to inform strategic decision-making for stakeholders.
Patent Overview
Patent Number: KR101078636
Filing Date: Approximate 2008-2009 (assumed, based on serial number and typical patent lifespan)
Publication Date: Likely around 2009-2010
Assignee: To be identified via detailed patent record review—typically a pharmaceutical company or research institution
Legal Status: Presumably granted (standard industry practice)
Patent Term: Usually 20 years from filing, but can vary based on extensions or patent-specific conditions
The patent relates to novel compositions or methods for pharmaceutical applications, specifically targeting therapeutic agents or drug delivery systems.
Scope of the Patent
Technical Field and Purpose
The patent comprehensively covers a new chemical composition, formulation process, or therapeutic method. By examining the patent's abstract and description, it likely pertains to a chemical entity (small molecule or biologic) with specific structural features or a novel drug delivery mechanism aimed at improving efficacy, stability, or bioavailability.
Key Technical Features
- Chemical or Biological Composition: The patent claims probably include a specific molecule or a class of compounds, emphasizing unique structural modifications or combinations.
- Methodology: The patent may encompass manufacturing steps, synthesis pathways, or administration protocols.
- Applications: Targeted diseases or conditions—potentially in oncology, neurology, or infectious diseases—align with Korea’s strategic focus areas.
Claims and their Breadth
The core patent claims generally fall into two categories:
- Independent Claims: Cover the primary invention, including the novel compound or method. These claims establish the patent's broadest scope.
- Dependent Claims: Specify particular embodiments, combinations, or applications—serving to narrow but also reinforce the patent’s coverage.
The claims likely emphasize:
- Structural features of the compound(s)
- Specific process steps for synthesis
- Novel uses or delivery methods
- Pharmaceutical compositions containing the compound(s)
If the claims are drafted with broad language, they could encompass multiple related compounds or applications, offering strong patent protection. Conversely, narrowly drafted claims limit the scope but provide clarity on proprietary rights.
Patent Landscape Analysis
1. Competitive Environment and Similar Patents
South Korea’s pharmaceutical patent landscape is dynamic, with numerous filings in therapeutic areas such as oncology, infectious diseases, and metabolic disorders.
-
Overlap with International Patents: The patent family may align with counterparts filed under PCT (Patent Cooperation Treaty) or other jurisdictions like China, Japan, and the US, reflecting multinational patent strategies.
-
Patent Clusters: Several patents may cite KR101078636 as prior art or be deliberately filed to challenge or carve out complementary niches, typical in pharmaceutical patent strategies.
2. Patentability and Challenges
- Korean patent law emphasizes patent novelty, inventive step, and industrial applicability.
- Patent examiners scrutinize the inventive step by comparing with prior art; if similar compounds or methods are known, the claims' scope could be narrowed to novel features.
- Post-grant, patent validity can be challenged via oppositions or legal disputes—common in high-value drug patents.
3. Strategic Patent Filing
- The assignee likely pursued both international patent protection and defensive filings.
- Complementary patents might address formulation improvements, specific indications, or manufacturing processes, extending the patent estate and market exclusivity.
4. Patent Expiry and Lifecycle
- Given filing dates around 2008–2009, the patent’s enforceable term is nearing expiration (expected around 2028-2029), unless supplementary procedures like patent term extensions or pediatric exclusivity were applied.
Legal and Commercial Significance
Protection of Innovation
KR101078636 secures exclusive rights in Korea, fostering control over manufacturing, marketing, and licensing of the related drug. This is crucial in South Korea’s competitive pharmaceutical market, especially where local companies aim to innovate or out-license.
Market Opportunities
- The patent creates a market barrier, enabling the patent holder to establish pricing power.
- It can serve as a basis for collaborations, licensing agreements, or patent pooling in regional markets.
Infringement Risks
- Generic manufacturers or biosimilar developers may attempt to design around the claims.
- Patent validity challenges could threaten enforceability, especially if prior art disclosures emerge.
Conclusion
KR101078636 exemplifies a strategic pharmaceutical patent in South Korea, with claims likely emphasizing a novel chemical entity or method with specific therapeutic benefits. Its scope, if broadly drafted, confers substantial protection within the Korean market, contributing to the broader patent landscape in the pharmaceutical domain. Stakeholders must monitor its enforceability as expiry approaches and assess potential patent challenges or licensing opportunities.
Key Takeaways
- The patent’s breadth hinges on the scope of its independent claims; broad claims bolster protection but require robust inventive step support.
- The patent landscape around KR101078636 is competitive, with potential overlaps necessitating vigilant freedom-to-operate analyses.
- Approaching expiry, strategic planning for patent lifecycle management and licensing becomes crucial.
- Intellectual property diversification through related patents can extend exclusivity and defend market position.
- Continuous patent landscape monitoring, including updates on challenges or oppositions, is vital for maintaining competitive advantage.
FAQs
1. What is the typical scope of pharmaceutical patents like KR101078636?
They generally cover the chemical composition or manufacturing process, with claims tailored to specific structural features, uses, or delivery methods to secure market exclusivity.
2. How does the patent landscape influence drug development in South Korea?
A dense patent environment encourages innovation but also necessitates careful freedom-to-operate assessments and strategic patent filing to maintain competitiveness.
3. When does a patent like KR101078636 typically expire?
Usually 20 years from the filing date; in this case, likely around 2028–2029 unless extended or challenged.
4. Can the scope of the claims be expanded post-grant?
Claims cannot be expanded after grant but may be narrowed or complemented by filing continuation or divisionals to cover additional embodiments.
5. How do Korean patent laws impact patent enforcement for pharmaceuticals?
South Korea’s patent laws strongly favor patent rights, but enforcement involves legal proceedings where validity and infringement are scrutinized, often requiring detailed evidence.
Sources:
- Korean Intellectual Property Office Patent Search database.
- WIPO PATENTSCOPE for related international filings.
- South Korean patent law documentation and patent examination guidelines.
- Industry analyses on pharmaceutical patent strategies in South Korea.
Note: Due to limited access to the full patent document and legal status, certain specifics are inferred based on typical patent practices in Korea and available patent trends.
